Journal of the National Cancer Institute

The Journal of the National Cancer Institute (print ISSN: 0027-8874, online ISSN: 1460-2105) publishes peer-reviewed original research from around the world and is internationally acclaimed as the source for the most up-to-date news and information from the rapidly changing fields of cancer research and treatment. For the past several years, the JNCI has been ranked as one of the most-cited original-research cancer journals by the Institute of Scientific Information in its annual Journal Citation Reports.

Publisher
Oxford University Press
History
1959–present
Website
https://academic.oup.com/jnci
Impact factor
12.589 (2016)

Some content from Wikipedia, licensed under CC BY-SA

Oncology & Cancer

Predicting response to adoptive cell therapies in cancer

Immunotherapy has changed the way oncology patients are treated. Immunotherapy approaches, including the use of immunomodulatory agents to enhance anti-cancer responses and the recent development of adoptive cell therapies ...

Oncology & Cancer

Study casts doubt on impact of menthol-flavored tobacco ban

A ban on the sale of menthol-flavored cigarettes that the U.S. Food and Drug Administration (FDA) is on track to implement may have unintended consequences, according to a study by researchers from Vanderbilt University Medical ...

Oncology & Cancer

Cancer burden facing Asian Americans partly caused by racism

The Journal of the National Cancer Institute (JNCI) published a commentary today on the significant cancer disparities facing Asian Americans. The article is authored by seven researchers from across the country who participated ...

Oncology & Cancer

Blood test figures in cancer risk for people with HIV

In the clinical care of people living with HIV, various types of blood cells are routinely counted to assess the immune system, among them CD4+ cells, or T helper cells, and CD8+ cells, or cytotoxic T cells.

page 1 from 37